Actualizaciòn de las principales medidas de prevención en la aparición de la preeclampsia

Abstract

Preeclampsia is a serious obstetric complication that affects maternal and neonatal health. This study reviews the effectiveness of aspirin as a preventive intervention in high-risk pregnant women. Through a review of randomized clinical trials, cohort studies and narrative reviews, it was identified that low doses of aspirin (25 mg to 100 mg) can significantly reduce the incidence of preeclampsia and its associated complications. However, response varies among women and adherence and accurate dosing are crucial. Some researchers also highlighted the potential benefits of calcium, especially in women with diets low in this mineral. In conclusion, the administration of aspirin in specific doses has been shown to be an effective and safe preventive strategy against preeclampsia in high-risk populations, although constant monitoring and particular attention to the dose and timing of treatment initiation are required.